Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population

Table 6 shows GHQ positive and GHQ negative in the vitiligo group in comparison with the controls

	n	GHQ^a(Mean ± SD)	p-value	GHQ -^b n (%)	GHQ + ^c n (%)	p-value
Case	99	26.46 ± 15.183	0.036	50 (50.5)	49 (49.5)	0.018
Control	100	22.12 ± 13.852	0.036	67 (67.0)	33 (33.0)	0.018
Case
Women	68	27.74 ± 15.554	0.219	33 (48.5)	35 (51.5)	0.666
Men	31	23.68 ± 14.181	0.219	17 (54.8)	14 (45.2)	0.666
Control
Woman	65	20.35 ± 13.008	0.082	45 (69.2)	20 (30.8)	0.656
Men	35	25.40 ± 14.939	0.082	22 (62.9)	13 (37.1)	0.656
Women
Case	68	27.74 ± 15.554	0.004	33 (42.3)	35 (63.6)	0.022
Control	65	20.35 ± 13.008	0.004	45 (57.7)	20 (36.4)	0.022
Men
Case	31	23.68 ± 14.181	0.634	17 (43.6)	14 (51.9)	0.618
Control	35	25.40 ± 14.939	0.634	22 (56.4)	13 (48.1)	0.618

ISSN: 1477-7525